In recent weeks, amid broader questions about the surge of the delta coronavirus variant in the U.S. and the vaccination campaign to counter it, journalists have periodically pressed health officials as to when the Food and Drug Administration might fully approve the vaccines, which had been administered, up to now, under emergency-use authorization.
